MX2009004748A - Interaccion orientada nbs1-atm para sensibilizar celulas cancerosas a radioterapia y quimioterapia. - Google Patents

Interaccion orientada nbs1-atm para sensibilizar celulas cancerosas a radioterapia y quimioterapia.

Info

Publication number
MX2009004748A
MX2009004748A MX2009004748A MX2009004748A MX2009004748A MX 2009004748 A MX2009004748 A MX 2009004748A MX 2009004748 A MX2009004748 A MX 2009004748A MX 2009004748 A MX2009004748 A MX 2009004748A MX 2009004748 A MX2009004748 A MX 2009004748A
Authority
MX
Mexico
Prior art keywords
chemotherapy
cancer cells
nbs1
radiotherapy
targeting
Prior art date
Application number
MX2009004748A
Other languages
English (en)
Inventor
Bo Xu
Mickael J Cariveau
Original Assignee
Southern Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Res Inst filed Critical Southern Res Inst
Publication of MX2009004748A publication Critical patent/MX2009004748A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/43—Sweetening agents, e.g. thaumatin, monellin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Abstract

En este documento se proporcionan composiciones y métodos para su uso en sensibilización de células cancerosas a la radiación y quimioterapia.
MX2009004748A 2006-10-30 2007-10-30 Interaccion orientada nbs1-atm para sensibilizar celulas cancerosas a radioterapia y quimioterapia. MX2009004748A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86345706P 2006-10-30 2006-10-30
PCT/US2007/022886 WO2008054726A2 (en) 2006-10-30 2007-10-30 Targeting nbs1-atm interaction to sensitize cancer cells to radiotherapy and chemotherapy

Publications (1)

Publication Number Publication Date
MX2009004748A true MX2009004748A (es) 2009-08-25

Family

ID=39344878

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004748A MX2009004748A (es) 2006-10-30 2007-10-30 Interaccion orientada nbs1-atm para sensibilizar celulas cancerosas a radioterapia y quimioterapia.

Country Status (9)

Country Link
US (1) US20100120679A1 (es)
EP (1) EP2091964A2 (es)
JP (1) JP2010508022A (es)
KR (1) KR20090102744A (es)
CN (1) CN101631799A (es)
AU (1) AU2007314366A1 (es)
CA (1) CA2674238A1 (es)
MX (1) MX2009004748A (es)
WO (1) WO2008054726A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8118754B1 (en) 2007-11-15 2012-02-21 Flynn Edward R Magnetic needle biopsy
US9964469B2 (en) 2005-02-28 2018-05-08 Imagion Biosystems, Inc. Magnetic needle separation and optical monitoring
US8841414B1 (en) * 2006-01-27 2014-09-23 University Of Mississippi Medical Center Targeted delivery of therapeutic peptides by thermally responsive biopolymers
WO2011057146A1 (en) 2009-11-06 2011-05-12 Scientific Nanomedicine, Inc. Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof
US8447379B2 (en) 2006-11-16 2013-05-21 Senior Scientific, LLC Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof
US10194825B2 (en) 2009-11-06 2019-02-05 Imagion Biosystems Inc. Methods and apparatuses for the localization and treatment of disease such as cancer
WO2012146259A1 (en) 2011-04-29 2012-11-01 Jens Overgaard Method for determining clinically relevant hypoxia in cancer
WO2013098339A1 (en) * 2011-12-27 2013-07-04 Universite Pierre Et Marie Curie (Paris 6) Anti-tumor adjuvant therapy
GB201209517D0 (en) * 2012-05-29 2012-07-11 Univ Birmingham Nanoparticles
CN104046644A (zh) * 2013-03-14 2014-09-17 中国科学院上海生命科学研究院 人源化小鼠模型的构建方法和应用
KR101447901B1 (ko) * 2013-04-16 2014-10-16 한양대학교 산학협력단 지방세포 표적 비바이러스성 유전자 전달체
WO2015128179A1 (en) * 2014-02-27 2015-09-03 Koninklijke Philips N.V. Medical instrument for high dose rate brachytherapy
WO2017004136A1 (en) 2015-06-30 2017-01-05 Tela Bio, Inc. Corner-lock stitch patterns
EP3324882B1 (en) 2015-07-21 2023-10-25 Tela Bio, Inc. Compliance control stitching in substrate materials
WO2017189772A1 (en) 2016-04-26 2017-11-02 Tela Bio, Inc. Hernia repair grafts having anti-adhesion barriers
KR101875111B1 (ko) * 2016-04-29 2018-07-09 한국수력원자력 주식회사 저선량 방사선을 이용한 암화유전자 Ras-유도 악성 암화 억제
SG10202107725RA (en) * 2017-02-16 2021-09-29 Firststring Research Inc Composition and methods for preventing radiation injury and promoting tissue regeneration
EP3612187B1 (en) 2017-04-21 2022-04-13 Lunella Biotech, Inc. Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs)
EP3612177A4 (en) 2017-04-21 2021-01-13 Lunella Biotech, Inc. TARGETING HYPOXIC CARCINOUS STEM CELLS (SCC) USING DOXYCYCLINE: IMPLICATIONS FOR IMPROVING ANTI-ANGIOGENIC THERAPY
EP3624840A4 (en) 2017-05-19 2021-03-10 Lunella Biotech, Inc. ANTIMITOSCINE: TARGETED INHIBITORS OF MITOCHONDRIAL BIOGENESIS TO DESCRIBE CANCER STEM CELLS
US11667639B2 (en) 2017-06-26 2023-06-06 Lunella Biotech, Inc. Mitoketoscins: mitochondrial-based therapeutics targeting ketone metabolism in cancer cells
WO2019173792A1 (en) * 2018-03-09 2019-09-12 Tela Bio, Inc. Surgical repair graft
EP3934575A4 (en) 2019-03-08 2022-12-28 Tela Bio, Inc. TEXTURED MEDICAL TEXTILES
WO2023069094A1 (en) * 2021-10-20 2023-04-27 Castor Trevor P Method and apparatus for inactivating pathogens in units of whole blood using superparamagnetic nanoparticles coated with chemiluminescence reagents and broad-spectrum anti-viral therapeutics
CN115300449B (zh) * 2022-02-07 2023-06-27 郑州大学第一附属医院 榄香烯在制备抑制肿瘤耐药性的控释制剂中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077880A (en) * 1997-08-08 2000-06-20 Cordis Corporation Highly radiopaque polyolefins and method for making the same
US7122343B1 (en) * 1998-04-27 2006-10-17 Wisconsin Alumni Research Foundation Methods to alter levels of a DNA repair protein
US7074902B1 (en) * 1998-04-27 2006-07-11 Warf Wisconsin Alumni Research Foundation Antibody specific for a DNA repair protein
US6530944B2 (en) * 2000-02-08 2003-03-11 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US20030104427A1 (en) * 2001-06-25 2003-06-05 Petrini John H.J. Methods to modulate telomere structure and function

Also Published As

Publication number Publication date
WO2008054726A3 (en) 2009-02-05
CA2674238A1 (en) 2008-05-08
EP2091964A2 (en) 2009-08-26
WO2008054726A2 (en) 2008-05-08
KR20090102744A (ko) 2009-09-30
JP2010508022A (ja) 2010-03-18
AU2007314366A1 (en) 2008-05-08
US20100120679A1 (en) 2010-05-13
CN101631799A (zh) 2010-01-20

Similar Documents

Publication Publication Date Title
MX2009004748A (es) Interaccion orientada nbs1-atm para sensibilizar celulas cancerosas a radioterapia y quimioterapia.
HK1245143A1 (zh) 在癌症化療和放療時保護細胞的局部血管收縮劑製品和方法
TR201907783T4 (tr) Benzosulfonamit türevleri, bileşimleri ve kanser hücrelerinin metastazının önlenmesinde kullanımları.
MX346973B (es) Anticuerpos especificos de tumores y usos para los mismos.
NZ608142A (en) Amatoxin-conjugates with improved linkers
IN2014CN02501A (es)
TN2010000236A1 (en) Fused pyridine pyrimidine and triazine compounds as cell cycle inhibitors
EP2192922A4 (en) INTERNALIZING HUMAN MONOCLONAL ANTIBODIES TARGING PROSTATE <I> IN SITU CANCER CELLS </ I>
MX2013010286A (es) Conjugados de amatoxinas con enlaces mejorados.
EA201791843A3 (ru) Способы повышения эффективности folr1 терапии рака
EA201390642A1 (ru) Цитотоксические агенты, содержащие новые производные анзамитоцина
UY31432A1 (es) Compuestos de diarilhidantoina
MX2011010955A (es) Terapia complementaria contra el cancer.
EP2135600A4 (en) AGENT FOR TARGETING CANCER CELLS OR FIBROBLASTS ASSOCIATED WITH CANCER
DK2252322T3 (da) Vaccinesammensætninger
JO2833B1 (en) Amino pyrazole compound
WO2012012710A3 (en) Radiation sensitization agents for prostate cancer
EP2519542A4 (en) ANTI-CDH3 ANTIBODY AND ITS USE
EP2121988A4 (en) SURVIVAL AND RECIPIENT OF PROSTATE CANCER
MX364002B (es) Compuestos y composiciones activadoras de enzima.
IL197335A (en) Sensitization of cancer cells to treatment @ radioactive @ B @ Y @ agonists @ of endothelin
MX359209B (es) Terapia de combinacion de procaspasa para gliobastoma.
TN2011000250A1 (en) Prophylactic/therapeutic agent for cancer
ATE533861T1 (de) Mipol1-etv1-gen-neuanordnungen
EP2461813A4 (en) COMPOSITIONS AND METHODS FOR INDUCING APOPTOSIS IN PROSTATE CANCER CELLS

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal